2013
DOI: 10.1016/j.febslet.2013.03.019
|View full text |Cite
|
Sign up to set email alerts
|

Differential transport of Influenza A neuraminidase signal anchor peptides to the plasma membrane

Abstract: a b s t r a c tInfluenza A Neuraminidase is essential for virus release from the cell surface of host cells. Given differential structures of the N-terminal sequences including the transme mbrane domains of neuraminidase subtypes , we investigated their contribution to transport and localization of subtypes N1, N2 and N8 to the plasma membrane. We generated consensus sequences from all protein entries available for these subtypes. We found that 40N-terminal the forty N-terminal amino acids are sufficient to co… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
11
0

Year Published

2013
2013
2022
2022

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 13 publications
(11 citation statements)
references
References 23 publications
0
11
0
Order By: Relevance
“…This position is located in the transmembrane domain and is not likely to affect the structure of the NA pocket. Such a polymorphism has already been observed [28] but not analyzed functionally. This mutation may modify monomers in terms of their anchorage or interactions, with repercussions on NA expression on the virus surface.…”
Section: Discussionmentioning
confidence: 90%
“…This position is located in the transmembrane domain and is not likely to affect the structure of the NA pocket. Such a polymorphism has already been observed [28] but not analyzed functionally. This mutation may modify monomers in terms of their anchorage or interactions, with repercussions on NA expression on the virus surface.…”
Section: Discussionmentioning
confidence: 90%
“…In N1, three leading sites 59, 386 and 388 (70, 390, and 392 in N2 numbering), and trailing site 434, undergo host-specific position-specific glycosylation, likely affecting enzymatic activity of NA [39]. Leading sites 6 and 14 and trailing site 15 are located in the transmembrane domain, which affects viral sialidase activity through its effect on NA tetramer assembly and transport to the membrane [40,41]. Leading site 149 and trailing sites 83, 275, 267 and 287 (274, 266, and 286 in N2 numbering) affect sialic acid binding; mutations at sites 267 and 275 were also shown to affect resistance to oseltamivir, including the mutation at site 275 which gave rise to the common oseltamivir-resistant H1N1 subtype.…”
Section: Resultsmentioning
confidence: 99%
“…For example, sites in the signal peptide of HA appear to occasionally interact with sites in the transmembrane domain of NA, e.g., site H1-16 forms a putatively epistatic pair with site N1-15 (Table S6). These types of mutations likely affect the efficiency of membrane localization of the respective surface proteins [40], and mutations in the transmembrance domain may also influence NA activity through their effect on tetramer assembly [41].…”
Section: Discussionmentioning
confidence: 99%
“…The first 41 N-terminal amino acids of the influenza virus NA, a type II membrane protein with an uncleaved signal peptide, allow translocation and intracellular transport of transplanted sequences (21). Therefore, this sequence containing the signal peptide plus the following linker region (14 amino acids) was used to replace the signal peptide of Gp3.…”
Section: Resultsmentioning
confidence: 99%